{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:34:27Z","timestamp":1712190867437},"reference-count":13,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/ijn.ijn_262_20","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T08:11:48Z","timestamp":1646813508000},"page":"172","source":"Crossref","is-referenced-by-count":0,"title":["Role of Cinacalcet in Treating Cardiac Dysfunction Secondary to Hyperparathyroidism: A Case Series"],"prefix":"10.25259","volume":"32","author":[{"given":"Samridhi","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpana","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amish","family":"Udani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhukar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.339285-1","first-page":"1221\u201332","article-title":"Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease","author":"Webb","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-2","first-page":"1103\u20138","article-title":"Oral paricalcitol: Expanding therapeutic options for pediatric chronic kidney disease patients","author":"Freundlich","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00467-018-4096-y","article-title":"Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease","author":"Paris","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-4","first-page":"129\u201335","article-title":"Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease","author":"Arenas","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-5","first-page":"1\u201359","article-title":"KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease mineral and bone disorder (CKD-MBD)","author":"Kidney","year":"2011","journal-title":"Kidney Int Suppl ("},{"key":"key-10.4103\/0971-4065.339285-6","first-page":"145\u201354","article-title":"An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to<6 years with chronic kidney disease receiving dialysis","author":"Sohn","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-7","first-page":"475\u201386","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis","author":"Warady","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-8","doi-asserted-by":"crossref","first-page":"e20163789","DOI":"10.1542\/peds.2016-3789","article-title":"Successful reversal of furosemide-induced secondary hyperparathyroidism with cinacalcet","author":"Srivastava","year":"2017","journal-title":"Pediatrics"},{"key":"key-10.4103\/0971-4065.339285-9","first-page":"795\u2013800","article-title":"Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b","author":"Srivastava","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-10","first-page":"992\u20136","article-title":"Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets","author":"Srivastava","year":"2013","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/0971-4065.339285-11","first-page":"1747\u201350","article-title":"Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia","author":"Alon","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.339285-12","first-page":"658\u201366","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","author":"Alon","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.339285-13","first-page":"47\u201364","article-title":"Cinacalcet use in paediatric dialysis: A position statement from the European Society for paediatric nephrology and the chronic kidney disease-mineral and bone disorders working group of the ERA-EDTA","author":"Bacchetta","year":"2020","journal-title":"Nephrol Dial Transplant"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:46:16Z","timestamp":1712173576000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/role-of-cinacalcet-in-treating-cardiac-dysfunction-secondary-to-hyperparathyroidism-a-case-series\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"alternative-id":["339285"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_262_20","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}